Protein-maxxing, GLP-1s have US farmers betting on peas and lentils - Reuters
Protein-maxxing, GLP-1s have US farmers betting on peas and lentils Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPRHg1VUNVbjhYM3NwMWVyZDRuOXNIU3BPNnZPWWFDaWxDUGpGQnN0MlZYYWhybTc2YTJuVS1IY1JxWEtJc3JCTmNpeUcyemI5SHZZeEI0cG5CNFdPU3FfaTl2Wm9qeTJFSDlMdlBkRU81aW5JbklzZVJ3SU01RFU3cWtLVl94cklOWTd3OWdocWJJVE1GRXg5YzFRU1lmSUN3b2M4VWhjUQ?oc=5" target="_blank">Protein-maxxing, GLP-1s have US farmers betting on peas and lentils</a> <font color="#6f6f6f">Reuters</font>
U.S. farmers are increasingly planting peas and lentils due to rising demand for protein-rich foods, driven by the popularity of GLP-1 medications and the 'protein-maxxing' trend.
The rise of GLP-1 medications has led to a surge in protein-rich food products, influencing American eating habits and marketing strategies.
Similar Stories
Related coverage based on topic and tags
US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts - Reuters
US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts Reuters
August 21, 2026 at 07:07 PMHard-handed Indian official urges food firms to be ethical amid labelling, ingredients dispute - Reuters
Hard-handed Indian official urges food firms to be ethical amid labelling, ingredients dispute Reuters
August 28, 2026 at 01:39 PM| Reuters - Reuters
| Reuters Reuters
August 27, 2026 at 01:06 AMUS widens lettuce-related cyclosporiasis probe to 20 states - Reuters
US widens lettuce-related cyclosporiasis probe to 20 states Reuters
August 27, 2026 at 09:27 PMEXCLUSIVE: US produce supplier Taylor Farms frequently fails to disclose workplace injury tallies, records show - Reuters
EXCLUSIVE: US produce supplier Taylor Farms frequently fails to disclose workplace injury tallies, records show Reuters
August 26, 2026 at 06:04 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AM